🚚 Free next-day tracked delivery on in-stock orders over £50 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free next-day tracked delivery on in-stock orders over £50 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free → 🚚 Free next-day tracked delivery on in-stock orders over £50 🖊️ Peptide Pens → 🖊️ Retatrutide Pens: 20mg £124.99 · 40mg £159.99 → 🎬 View Peptide Videos → 🔬 New: Senolytics & Longevity Research. Explore the science → 👤 Members save 10% on eligible products. Join free →

PT-141

For In-Vitro Laboratory Research Use Only • Not for Human or Veterinary Use

PT-141 (Bremelanotide) Research Peptide — 10mg

PT-141 (Bremelanotide, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) studied in laboratory research as a non-selective melanocortin receptor agonist (primarily MC3R and MC4R). Supplied as a 10mg lyophilised research vial with a third-party batch Certificate of Analysis (Report No. LDA22161262 — >99.63% HPLC purity).

For in-vitro laboratory research use only. Not for human or veterinary use.

£24.99 / vialFrom £21.24 / vial (15% Multi-Vial Savings)

10 in stock

10 in stock

🧪 MULTI-VIAL RESEARCH SAVINGS Buy 2 Save 10% · Buy 3+ Save 15%
1 Vial Standard £24.99 / vial
Buy 2 Vials Save 10% £22.49 / vial
Buy 3+ Vials Save 15% £21.24 / vial
Mix & match vials — 10% off 2 vials and 15% off 3+ vials auto-applies in your basket + Free Tracked 24 Delivery over £50.
💧 Reconstitution Bundle: add 10ml Bacteriostatic Water (£5.99) with any lyophilised peptide — FREE on orders over £100.
💧 + Add 10ml BAC Water (£5.99 / Free £100+)

FOR IN-VITRO LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN OR VETERINARY USE

These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

About PT-141 (Bremelanotide)

PT-141 (also known in published literature as Bremelanotide) is a synthetic cyclic lactam heptapeptide with the amino acid sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. PT-141 is investigated in preclinical and receptor-binding studies for its selective interaction with central melanocortin receptors, particularly MC3R and MC4R. PubChem lists its molecular formula as C50H68N14O10, with a molecular weight of approximately 1025.2 g/mol (CAS 189691-06-3).

The product supplied by Corex Vitality™ is an analytical reference and laboratory research compound for in vitro research use only. Browse all batch certificates on our COA and verification page.

Product specifications

Compound PT-141 (Bremelanotide)
Form Lyophilised (freeze-dried) powder in a sealed research vial
Size 10mg (actual tested fill: 10.86mg per COA LDA22161262)
Sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
CAS Number 189691-06-3
Molecular formula C50H68N14O10 (PubChem)
Molecular weight 1025.2 g/mol (PubChem)
Chromatographic Purity (HPLC) >99.63% ± 0.18% (View Batch COA LDA22161262)
Endotoxin & Sterility 0.27 EU/mg (≤0.50 EU/mg spec) · Sterility: PASS (No growth)
Availability In stock — UK tracked dispatch (1–2 working days)

Storage and handling

Storage & Handling — Corex Vitality™ research vials

  • As supplied: freeze-dried (lyophilised) powder in a sealed vial. Room-temperature transit is normal for dry peptides.
  • Longer storage: keep the vial tightly closed in a freezer at −20 °C or colder, dry and away from light. Colder is better for long archives.
  • Short-term: a laboratory fridge (2–8 °C) is fine for vials you plan to open soon.
  • Before opening: let the closed vial warm to room temperature, ideally in a desiccator, so moisture does not condense on the powder. Work quickly and reseal tightly; absorbed moisture lowers the real peptide content.
  • Dissolving: choose a solvent based on the sequence (see the compound note below) and test a small portion first. Swirl gently; brief sonication in a water bath can help. Do not heat.
  • Once in solution: make up only what you need. Split any solution you keep into single-use aliquots, freeze at −20 °C or colder and thaw each aliquot only once. Peptides keep far less well in solution than as dry powder.
  • Safety: handle in a suitable laboratory with appropriate PPE, following your institution’s safety procedures, and avoid breathing the powder. Keep out of reach of children.

Compound note: Oxidation-sensitive: cyclic peptide containing tryptophan, which is light- and oxidation-sensitive. Protect from light and use degassed solvent. Basic: a trace of dilute acetic acid before dilution if needed.

For in-vitro laboratory research use only. Not for human or veterinary use. General guidance paraphrased from Bachem: Handling and Storage Guidelines for Peptides and Peptide Solubility.

Quality and testing

The published PT-141 10mg batch COA (Lingda Laboratory, Report No. LDA22161262) reports HPLC-UV/VIS purity and quantity, heavy metals (ICP-MS), endotoxin (LAL assay) and sterility results. You can inspect the full Certificate of Analysis directly via the PT-141 10mg Batch COA (Report No. LDA22161262) or search by report number on our COA Verification page.

Research use only

For in-vitro laboratory research use only. Not for human or veterinary use. These products are research chemicals. They are not medicines, food, or supplements. They have not been evaluated by the MHRA, FDA, or any other regulatory body. Not intended to diagnose, treat, cure, or prevent any disease. All descriptions are for reference and research documentation purposes only. By purchasing, you confirm you are aged 18+ and using these products exclusively for in vitro laboratory research.

Research you can verify.

Get Corex Vitality™ Research Updates

Get new Learning Hub articles and stock updates. No spam. Unsubscribe any time.

We will send you an email to confirm. Read our privacy policy.

🎬 Scientific Explainer Video · What It Is For & How It Works

PT-141 (Bremelanotide) — Laboratory Mechanism & Research Overview

⬇ Download Video (MP4) All Peptide Videos →
🔬 What Is This Peptide Researched For?
  • Studying central nervous system melanocortin receptor (MC3R and MC4R) activation pathways
  • Comparing central hypothalamic neural signalling vs peripheral vascular PDE5 pathways
  • Investigating cyclic lactam-bridge peptide stability and blood–brain barrier receptor kinetics
⚙️ How Does It Work? (Mechanism of Action)
1. MC4R & MC3R GPCR Binding: Binds central melanocortin-4 and melanocortin-3 receptors in hypothalamic nuclei.
2. Gs-Coupled cAMP Elevation: Stimulates adenylyl cyclase, increasing intracellular cAMP and PKA phosphorylation.
3. Dopaminergic & Autonomic Readout: Activates downstream central nitric oxide and dopaminergic neurotransmission pathways.
📚 Peer-Reviewed Literature · PubMed Indexed

Published Research — PT-141 (Bremelanotide / Cyclic Melanocortin Heptapeptide)

NCBI PubMed Database ↗ Verify Batch COAs →
  1. [1] Fotsch C et al. · Bioorg Med Chem Lett (2003)

    1H-NMR spectroscopy and distance-restraint conformational study of the cyclic lactam melanocortin agonist scaffold Ac-Nle-cyclo[Asp-Pro-D-Phe-Arg-Trp-Lys] defining the spatial beta-turn orientation of the His/Pro-D-Phe-Arg-Trp pharmacophore.

    PMID: 12824029 ↗ DOI: 10.1016/s0960-894x(03)00412-8 ↗
  2. [2] Sun H et al. · Bioorg Med Chem (2004)

    Nuclear magnetic resonance (NMR) and 3D-QSAR pharmacophore modelling of cyclic lactam heptapeptides derived from the Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] scaffold, mapping steric and hydrophobic determinants of human MC4R selectivity.

    PMID: 15110848 ↗ DOI: 10.1016/j.bmc.2004.03.017 ↗
  3. [3] Zhang H et al. · Cell Res (2021)

    Cryo-electron microscopy structure determination of the human melanocortin-4 receptor–Gs protein complex bound to cyclic peptide agonists including bremelanotide (PT-141), resolving calcium-cofactor coordination and transmembrane helix 6 activation.

    PMID: 34433901 ↗ DOI: 10.1038/s41422-021-00552-3 ↗
  4. [4] Suzuki S et al. · Anticancer Res (2024)

    In-vitro glioblastoma cell-culture assay investigating melanocortin receptor agonist bremelanotide (PT-141) effects on cellular proliferation, apoptosis markers, and intracellular survivin protein expression.

    PMID: 39197897 ↗ DOI: 10.21873/anticanres.17214 ↗

References are provided for scientific context only. All Corex Vitality™ compounds are supplied strictly for in-vitro laboratory research use (RUO).